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Myopathies are notably associated with mutations in genes encoding proteins known
to be essential for the force production of skeletal muscle fibers, such as skeletal
alpha-actin. The exact molecular mechanisms by which these specific defects induce
myopathic phenotypes remain unclear. Hence, in the present study, to better understand
actin dysfunction, we conducted a molecular dynamic simulation together with ex vivo
experiments of the specific muscle disease-causing actin mutation, D286G located
in the actin-actin interface. Our computational study showed that D286G impairs the
flexural rigidity of actin filaments. However, upon activation, D286G did not have any
direct consequences on actin filament extension. Hence, D286G may alter the structure
of actin filaments but, when expressed together with normal actin molecules, it may only
have minor effects on the ex vivo mechanics of actin filaments upon skeletal muscle fiber
contraction.
Keywords: actin mutation, myopathy, muscle force, actin mechanics, muscle fiber
INTRODUCTION
Congenital myopathies are genetic muscle diseases that start at a very young age. Patients
experience weakness in the limb, masticatory and respiratory muscles which can result in severe
debilitation, loss of independence and the need for constant care (Nowak et al., 2013; Tajsharghi and
Oldfors, 2013). The related medical expenses and economic consequences are therefore enormous
(Nowak et al., 2013; Tajsharghi and Oldfors, 2013). Hence, it is of vital importance to get a detailed
understanding of the molecular pathophysiology for this class of disorders.
Over the last 20 years, a large number of reports have associated these congenital myopathies
with mutations in genes encoding proteins fundamental for myofiber structure and function
(Nowak et al., 2013; Tajsharghi and Oldfors, 2013). Among these genes isACTA1, which encodes the
skeletal muscle protein alpha-actin (Nowak et al., 2013). Actin is essential for muscle contraction
and force generation. Actin monomers of the thin filaments directly interact with myosin molecules
to form cross-bridges that initiate force development and motion at the sarcomere and myofiber
levels (Gordon et al., 2000). Missense ACTA1 mutations, and thus, single amino acid replacements
in actin proteins, are now known to depress myosin cross-bridge formation and myofiber force
production explaining in part why patients experience muscle weakness and have myopathic
phenotypes (Lindqvist et al., 2012, 2013, 2016; Ochala et al., 2012, 2015).
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When carefully looking at the 200 different single residue
substitutions in actin inducing inherited myopathies, only a small
portion of these is located on amino acids directly interacting
with myosin, or with tropomyosin and/or troponin molecules,
which are also involved with actin binding. It is then unclear how
the remaining defects interfere with cross-bridge functioning
(Nowak et al., 2013). In the present study, based on one of
our previous studies (Chan et al., 2016) and on computational
simulations (Kojima et al., 1994; Wakabayashi et al., 1994; Miller
et al., 2010) we aimed to test the hypothesis that one of the
major triggering factors of muscle weakness would be altered
actin filament structure. To verify this, we applied a unique
combination of molecular dynamics (MD) simulation and ex vivo
experiments (small-angle x-ray scattering). We focused our
attention on D286G which is located in subdomain 3 at the actin-
actin interface (Ravenscroft et al., 2011a). Even though D286G
does not have any known interaction with myosin, tropomyosin
and/or troponin molecules, it has been linked to improper
myosin binding (Ochala et al., 2012, 2015) and nemaline
myopathy in mice and humans (Ravenscroft et al., 2011a).
MATERIALS AND METHODS
Animals
After sacrifice, skeletal muscles (extensor digitorum longus,
EDL) were dissected from 3 to 4-month old male wild-type
and age-matched transgenic mice expressing the ACTA1 D286G
mutation. For a complete description of the transgenic mice,
please refer to Ravenscroft et al. (2011a). All procedures involving
animal care, welfare and handling were performed according to
institutional guidelines. They were reviewed and approved by the
Animal Ethics Committee of The University of Western Australia
(RA03/100/918).
Muscle Preparation and Fiber
Permeabilization
EDL muscles were placed in relaxing solution at 4◦C. Bundles
of approximately 50 myofibers were dissected free and then tied
with surgical silk to glass capillary tubes at slightly stretched
lengths. They were then treated with membrane-permeabilizing
solution (relaxing solution containing glycerol; 50:50 v/v) for 24 h
at 4◦C, after which they were transferred to −20◦C. In addition,
the muscle bundles were treated with sucrose, a cryo-protectant,
within 1–2 weeks for long-term storage (Frontera and Larsson,
1997). They were detached from the capillary tubes and snap
frozen in liquid nitrogen-chilled isopentane and stored at−80◦C.
Small-Angle X-Ray Scattering and
Analyses
Two to three days prior to X-ray recordings, bundles were de-
sucrosed, transferred to a relaxing solution and single myofibers
were dissected. Arrays of approximately 30 myofibers were
set up. For each myofiber, both ends were clamped to half-
split gold meshes for electron microscopy (width = 3 mm),
which had been glued to precision-machined ceramic chips
(width = 3 mm) designed to fit to a specimen chamber. The
arrays were then transferred to the skinning solution and stored
at−20◦C. Approximately 80 arrays were mounted (10 arrays per
mouse – four knock-in and four wild-type mice – corresponding
to approximately 2,400 attached fibers) (Ochala et al., 2015; Chan
et al., 2016).
On the day of X-ray recordings, arrays were placed in a
plastic dish containing a pre-activating solution and washed
thoroughly to remove the glycerol. They were then transferred to
the specimen chamber, capable of manual length adjustment and
force measurement (force transducer, AE801, Memscap, Bernin,
France), filled with a pre-activating solution. Mean sarcomere
length was measured (laser diffraction) and set to 2.50 µm.
Subsequently, X-ray diffraction patterns were recorded at 15◦C,
first in the pre-activating solution and then in the activating
solution (pCa 4.5) when maximal steady-state isometric force was
reached.
For each array, approximately 20 to 30 diffraction patterns
were recorded (depending on myofiber length) for each solution
at the BL45XU beamline of SPring-8. The wavelength was
0.1 nm, and the specimen-to-detector distance was 3.47 m to
maximize the spatial resolution to determine filament extension.
As a detector, a cooled CCD camera (C4880, Hamamatsu
Photonics; 1000 × 1018 pixels) was used in combination with an
image intensifier (VP5445, Hamamatsu Photonics). To minimize
radiation damage, the exposure time was kept low (1–2 s)
and the specimen chamber was moved by 100 µm after each
exposure. Moreover, we placed an aluminum plate (thickness,
0.35–0.5 mm) upstream of the specimen chamber. Following
the x-ray recordings, background scattering was subtracted, and
reflection intensities were determined as described elsewhere.
Note that in the literature, the determination of actin spacing (or
actin extensibility) is historically performed using actin layer line
(ALL) reflections, that is, the 6th ALL (ALL6, d = 5.9 nm) and 7th
ALL (ALL7, d = 5.1 nm) (Wakabayashi et al., 1994). However,
using ALL6 and ALL7 to assess the actin spacing leads to errors
(Chan et al., 2016). Hence, here, we used the 3rd order meridional
reflection of troponin (TN3, d = 12.9 nm) which has a stable
intensity in membrane-permeabilized myofibers set at a define
sarcomere length (Chan et al., 2016).
Relaxing and activating solutions contained 4 mM Mg-ATP,
1 mM free Mg2+, 20 mM imidazole, 7 mM EGTA, 14.5 mM
creatine phosphate, 324 U/mL creatine phosphokinase, 1000
U/mL catalase, and KCl to adjust the ionic strength to 180 mM
and pH to 7.0. Dithiothreitol (DTT) was also added (10 mM).
The pre-activating solution was identical to the relaxing solution,
except that the EGTA concentration was reduced to 0.5 mM. The
concentrations of free Ca2+ were 10−9.0 M (relaxing and pre-
activating solutions, pCa 9.0) and 10−4.5 M (activating solution,
pCa 4.5).
Molecular Dynamics Simulation
One actin filament containing the D286G mutants composed
of subunits with bound Mg2+-ADP was constructed. This was
based on vertebrate (rabbit) skeletal muscle actin Protein Data
Bank entry 2ZWH, with a high-affinity Mg2+ cation placed at
the nucleotide-binding site and the first solvation shell of explicit
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waters included. The filament contained 13-monomer subunits
as described in Saunders and Voth (2011); Fan et al. (2012, 2013).
The filament was solvated in explicit TIP3P water molecules, with
K+ and Cl− ions included at a final concentration of 0.18 M using
the solvate and autoionize tools in VMD (Humphrey et al., 1996).
Periodic boundary conditions were introduced such that the
filament was aligned to repeat along the z direction, interacting
with itself at the box edges.
The MD simulations were performed using NAMD 2.10
package (Phillips et al., 2005) and the CHARMM 22/27 force
field (MacKerell et al., 1998) with CMAP correction (Mackerell
et al., 2004). Electrostatic interactions were calculated using the
particle mesh Ewald sum method with a cutoff of 12 Å. All
hydrogen-containing covalent bonds were constrained by the
SHAKE algorithm, therefore allowing an integration time step
of 2 fs. Before production runs, an actin filament system was
energy minimized, heated, and pre-equilibrated for 100 ps in the
canonical ensemble while the protein backbone, the nucleotide,
the active site Mg2+, and water oxygen atoms were harmonically
restrained with spring constant 1 kcal/mol Å2. Simulations were
then continued in the constant NPT ensemble (310 K and
1 atm) for an additional 200 ps. Langevin thermostats with a
damping coefficient of 0.5 ps−1 were used to control the system
temperature. A Langevin-piston barostat with a piston period
of 2 ps and a damping time of 2 ps was used to control the
pressure. Constraints were next released step-wise (with spring
constant gradually decreased from 1 kcal/mol Å2 to 0 by steps
of 0.1 kcal/mol Å2) over a total of 100 ps before starting the
production runs. A total of 166 ns of data were generated for
the D286G actin filament systems. Only data after the system was
equilibrated (after 75 ns production run) were taken for further
analysis. The final 90 ns of data were used for analysis unless
otherwise specified. All quantities presented in this article are
the averaged value over all subunits and the simulation windows.
All MD data are analyzed based on the block averages method
(Frenkel and Smit, 2002). All errors in the MD results section
refer to standard deviation (SD).
Statistics
The unpaired Student’s t-test was applied, and in cases where
the data did not meet the criteria of normality (Kolmogorov–
Smirnov test, p < 0.05), the non-parametric Mann-Whitney
rank-sum test was performed.
RESULTS AND DISCUSSION
In the present work, we studied a missense ACTA1 mutation
resulting in the substitution of one single amino acid in the
skeletal alpha-actin protein (D286G, according to the standard
Human Genome Variation Society nomenclature) (Ravenscroft
et al., 2011a). By using a MD simulation, together with ex vivo
experiments consisting of X-ray diffraction, we observed that
D286G alters actin filamentous structure. We also showed that,
in contracting skeletal muscle fibers expressing both mutant and
normal actin monomers, such structural defects do not have any
major toxic consequences on actin mechanics.
TABLE 1 | Comparison of longitudinal and lateral contacts between filaments
containing D286G and wild-type (WT) filaments.
Equilibrated distance (A)
Residue ID D286G filament WT filamenta
Longitudinal contact
D-loop to C-term 41 vs. 374 12.51 (1.40) 13.09 (1.50)
61 vs. 374 22.78 (0.82) 23.29 (1.24)
45 vs. 370 14.68 (1.54) 14.85 (2.09)
D-loop to SD1 45 vs. 169 8.36 (1.73) 9.74 (1.74)
61 vs. 169 12.85 (0.81) 12.78 (1.40)
D-loop to SD3 62 vs. 288 7.52 (0.77) 7.52 (1.13)
SD4 to SD3 205 vs. 286 9.27 (0.73) 9.29 (0.53)
241 vs. 322 11.41 (1.74) 11.03 (1.76)
Lateral contact
H-plug vs. C 265 vs. 374 19.35 (0.98) 20.13 (1.15)
Standard deviations are included between brackets. C-term, C-terminus; D-loop,
DNase I-binding loop; SD1, subdomain 1; SD3, subdomain 3; and SD4,
subdomain 4. aData from Fan et al. (2013).
Actin Filaments Have Altered Flexural
Rigidity in the Presence of D286G
Even though we did not observe any change in the internal
structure of individual actin monomers with D286G,
interestingly, we found that intra-filament distances between
monomers were affected by the residue replacement. Indeed,
most of the longitudinal and lateral contact distances were lower
in filaments carrying D286G than in WT filaments (Table 1).
This is in agreement with another amino acid substitution in
the actin protein (H40Y) leading to myopathic features in mice
and humans (Lindqvist et al., 2013; Nguyen et al., 2011). In
the presence of D286G or H40Y, the DNase I-binding loop (or
D-loop, residues 38–52) appears to be involved in many of the
alterations. This particular loop plays a key role in the actin-actin
interface as it directly interacts with the C-terminus of the
adjacent subunit in actin filament (Dominguez and Holmes,
2011). Taken together, our data indicate that in the presence of
D286G or H40Y, individual actin monomers become closer.
To further investigate intra-filament changes, we assessed
the subunit geometries through coarse-graining residues into
relatively rigid sub-groups: residues 5–33, 80–147, and 334–349
as SG1; residues 34–39 and 52–69 as SG2; residues 148–179 and
273–333 as SG3; residues 180–219 and 252–262 as SG4. For the
analysis, we referred the centres of geometry (COGs) of these
residues as R1, R2, R3, and R4 (Chan et al., 2016; Table 2). We
then noticed a few differences between filament subunits carrying
D286G and WT filament subunits. The equilibrated R2–R1–R3
angles as well as R2–R1–R3–R4 dihedral angles were greater
in filament subunits containing D286G than in WT filament
subunits. This is in line with differences reported with H40Y
(Chan et al., 2016). All these findings indicate a change in the
actin filament stability in the presence of D286G or H40Y that
is related to modifications in the interactions between the D-loop
and adjacent subunits.
Finally, we calculated actin filament persistence length using
MD simulation (Supplementary Figure 1). This parameter was
larger (p < 0.002) in filaments containing D286G than in
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TABLE 2 | Coarse-grained (CG) representation of subunit geometries in filaments
expressing D286G and wild-type (WT) filaments.
Parameters D286G equilibrated WT equilibratedb
Bond (A) R1–R2a 21.84 (0.39) 22.99 (0.39)
R1–R3 24.92 (0.18) 24.85 (0.28)
R3–R4 24.87 (0.19) 24.97 (0.28)
Angle (◦) R1–R3–R4 74.74 (1.83) 74.42 (1.96)
R2–R1–R3 105.95 (1.57) 102.06 (2.06)
Dihedral (◦) R2–R1–R3–R4 12.01 (3.36) 10.27 (3.41)
Standard deviations are included between brackets. aResidue sets: R1: 5–33,
80–147, and 334–349; R2: 34–39 and 52–69; R3: 148–179 and 273–333; R4:
180–219 and 252–262. bData from Fan et al. (2013).
wild-type (WT) filaments (17.2 ± 6.0 and 9.80 ± 0.14 µm,
respectively). The increase in the persistence length of actin
filament demonstrates that D286G stiffens the filament. In other
words, the filament resilience increases with this mutation.
To understand the potential mechanisms, we measured the
crossover length of the filament with thirteen D286G subunits.
The crossover length was 356.85 ± 0.71 Å, which was smaller
than that of WT filament (365 ± 15 Å) with p < 0.00007
(McGough et al., 1997). Note that as our calculations did not
include phalloidin or other actin-binding proteins known to
stabilize the filaments, our WT value was shorter than the ones
previously reported (Yanagida et al., 1984; Gittes et al., 1993; Ott
et al., 1993).
We conclude that based on our data analysis, D286G results in
a decrease in the distance between the D-loop and the C-terminal
region as well as in the crossover length. It also induced an
increase in the persistence length. As this persistence length spans
beyond the distance between adjacent subunits, it is likely that a
cooperative mechanism between subunits exists in the presence
of D286G allowing a negative propagation to distant subunits.
Thin Filament Extension Upon Activation
Is Not Altered When D286G Is Expressed
Together With Normal Actin Monomers
As the above results from MD simulations imply that actin
filaments may have affected stabilities we measured their maximal
extensibility by recording and analyzing the actin spacing
via X-ray diffraction patterns. Relaxed and activated single
membrane-permeabilized myofibers from WT mice and mice
expressing both D286G and WT actin molecules were tested.
These experiments were possible, as muscles from transgenic
mice do not have any signs of sarcomeric ultrastructure
(Ravenscroft et al., 2011b).
We determined the actin spacing by using the third order
meridional reflection of troponin (TN3, d = 12.9 nm). As
previously reported (Chan et al., 2016) we subtracted the
background scattering, and then fitted the intensity profile of
TN3 to the Gaussian function (with its center being the position
of the peak). Data in the ranges of ±4 pixels as well as ±3
pixels from the observed peak were used (Chan et al., 2016).
To gain a reasonably high signal-to-noise ratio and to make the
curve fitting reliable, in the present study, we used a qualitative
approach where all the data obtained for all the arrays for each
group of mice were sum up. We then compared the mean
values. Hence, upon maximal activation, in WT myofibers, the
peak shifted by∼0.34 and∼0.31%, respectively (Supplementary
Figure 2). Interestingly, in myofibers carrying D286G, the peak
only moved by ∼0.18 and ∼0.13%, respectively (Supplementary
Figure 2). Hence, in contracting muscle fibers expressing D286G,
the actin filament extension appeared reduced by ∼50%. Actin
filament extensibility depends on myosin binding as well as
on force production (Gordon et al., 2000). As in the presence
of D286G, muscle fiber force generation is reduced by ∼50%
(Ochala et al., 2012) it is unlikely that our experimental
differences arise from a direct effect of the mutation on the ability
of actin filament to change their conformation during activation.
This result differs from the findings related to the H40Y amino
acid substitution (Chan et al., 2016). Several potential alternatives
may underlie this. First, it is plausible that the changes in actin
filament structure in the presence of D286G are less damaging
than H40Y. Second, as the amount of mutant actin molecules in
the myofibers used for our current experiments is∼25% (Ochala
et al., 2012) and as normal and D286G actin molecules are likely
to form heteropolymers, significant differences may be hindered.
CONCLUSION
To conclude, our computational study reveal that D286G
disrupts the D-loop interaction with neighboring actin
monomers, affecting the flexural rigidity. Despite this, when
D286G is mixed with its wild-type form, our ex vivo experiments
indicate that the mechanics of actin filaments is not directly
altered.
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